Involvement of Toll-Like Receptor 4 in Decreased Vasopressor Response Following Trauma/Hemorrhagic Shock: Erratum

. 2022 Jan 7;4(1):e0609. doi: 10.1097/CCE.0000000000000609

PMCID: PMC8747601 PMID: 35028586

In the article in the July 2021 compendium, the following disclosure was missing:

Dr. Schmid-Schonbein owns stock in Palisade Bio, a company to develop shock treatments.

REFERENCE

Mazor R, Dos Santos F, Joyce B, et al. : Involvement of Toll-Like Receptor 4 in Decreased Vasopressor Response Following Trauma/Hemorrhagic Shock. Crit Care Explor 2021; 3:e0469. [DOI] [PMC free article] [PubMed] [Google Scholar]